Mila Ogalla Toledo, Digestive Cancers Europe at Board Member, Communication Specialist, Patient Advocate, Public Speaker, and Project Manager, shared a post on LinkedIn:
“Currently celebrating my EUPATI Category 2 Non-Clinical Development certificate!
This might be my favourite one so far because we dived into biomarkers, genomics, proteomics, gene expression, epigenetics, metabolomics, gene and stem-cell therapy medicines…
And, after the VOICE course with Barts Cancer Institute (Queen Mary University of London) and Independent Cancer Patients’ Voice, I am utterly obsessed with all the things related to those topics!
So, not only was this module a tad easier for me, it was totally my cuppa!
Thank you, Digestive Cancers Europe for making this happen.”
More posts featuring Mila Ogalla Toledo.